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e have selectively inhibited Notch1 signaling in
oligodendrocyte precursors (OPCs) using the
Cre/loxP system in transgenic mice to investigate
the role of Notch1 in oligodendrocyte (OL) development
and differentiation. Early development of OPCs appeared
normal in the spinal cord. However, at embryonic day
17.5, premature OL differentiation was observed and ectopic
immature OLs were present in the gray matter. At birth, OL
W
 
apoptosis was strongly increased in 
 
Notch1
 
 mutant animals.
Premature OL differentiation was also observed in the
cerebrum, indicating that Notch1 is required for the correct
spatial and temporal regulation of OL differentiation in
various regions of the central nervous system. These findings
establish a widespread function of Notch1 in the late steps
of mammalian OPC development in vivo.
 
Introduction
 
Signaling through the Notch pathway is involved in various
cell fate decisions, in particular in maintenance of precur-
sor cells in an undifferentiated state until they are competent
to respond to inductive cues (for reviews see Artavanis-
Tsakonas et al., 1995; Robey, 1997; Weinmaster, 1998).
In this context, Notch signaling plays a key role in tissue-
autonomous fate determination in central nervous system
(CNS)* development, in a process referred to as a lateral
inhibition (Artavanis-Tsakonas et al., 1999), and also regulates
mammalian neurogenesis (Lütolf et al., 2002). A role of
Notch signaling in the regulation of terminal neural differ-
entiation also has been found in the development and re-
modeling of dendrites (Berezovska et al., 1999; Franklin
et al., 1999; Sestan et al., 1999; Redmond et al., 2000).
In vertebrate glial cell development, the Notch pathway
has been implicated in a number of crucial events. Activated
Notch promotes the formation of radial glia in the fetal fore-
brain (Gaiano et al., 2000; Chambers et al., 2001), Schwann
cells in dorsal root ganglia (Wakamatsu et al., 2000), and
Müller glia in the retina (Furukawa et al., 2000). In cell cul-
ture, even transient activation of Notch strongly promotes
the differentiation of adult hippocampus-derived multipotent
progenitors into astroglia (Tanigaki et al., 2001), and of
neural crest stem cells into the Schwann cell lineage (Morrison
et al., 2000).
However, the oligodendrocyte (OL) lineage appears to
respond somewhat differently. Activation of Notch signaling
suppresses rather than promotes the differentiation of OLs
from multipotent progenitor cells (Gaiano et al., 2000;
Tanigaki et al., 2001). Furthermore, a potential regulatory
role of the Notch pathway in mammalian oligodendrocyte
precursor cell (OPC) differentiation has been suggested by
cell culture studies showing that OPCs derived from the
postnatal rat optic nerve could be inhibited in their differen-
tiation by incubation with Notch ligands (Wang et al., 1998).
How proliferation and differentiation are regulated in the
OL lineage is only partially understood (Barres et al., 1992;
Barres and Raff, 1994; Raff et al., 1998; Kondo and Raff,
2000a,b; Qi et al., 2001; Wang et al., 2001; Zhou et al.,
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2001). On the basis of morphology and molecular pheno-
type, cells of the OL lineage can be grouped into OPCs, im-
mature OLs (premyelinating), and mature OLs (myelinat-
ing cells; Gard and Pfeiffer, 1990; Hardy and Reynolds,
1991; Armstrong et al., 1992; Miller, 1996). OPCs of the
developing spinal cord are generated along the length of the
neural tube from a narrow zone in the ventral region of the
neuroepithelium (Noll and Miller, 1993; Pringle and Rich-
ardson, 1993; Yu et al., 1994). Determination of the OL
lineage is promoted by the transcription factors Olig1,
Olig2, and Nkx2.2 (Lu et al., 2001; Zhou et al., 2001; Fu et
al., 2002), but the exact nature of the interplay among them
is not clear. OPCs arising in the ventral spinal cord subse-
quently proliferate and disperse throughout the developing
CNS (for reviews see Miller, 1996; Richardson et al., 1997;
Spassky et al., 2000). 
Postmitotic OLs appear first in the ventral funiculus and
later in the dorsal and lateral funiculi, the large axonal bun-
dles that become the white matter tracts of the spinal cord
(Jordan et al., 1989; Yu et al., 1994). However, it remains an
open question how OPCs are able to migrate through an al-
ready established neuronal system around, over, and along the
axons they may ultimately myelinate, before differentiating at
the appropriate time point (Blaschuk and ffrench-Constant,
1998). Progression past the OPC stage is strongly delayed and
reduced in Nkx2.2
 

 
/
 

 
 mice, suggesting a possible role for this
transcription factor in later development of OLs (Qi et al.,
2001). Ectopic OPCs arising on overexpression of Notch1 to-
gether with Olig2 in chick spinal cord do not mature, which
is consistent with a negative role for Notch1 in late stages of
differentiation (Zhou et al., 2001). In contrast, Givogri et al.
(2002) have reported a transient increase of myelination in
some parts of the CNS during the early postnatal weeks in
heterozygous-null Notch1 mutants. In vitro studies and cor-
relative evidence based on the regulation of Notch1 and its
ligand Jagged1 in the developing optic nerve have also impli-
cated the Notch pathway in the control of the timing of OPC
differentiation (Wang et al., 1998). This is a tantalizing idea
supporting a model in which loss of responsiveness to growth
factors may permit OPC differentiation, but local cues (e.g.,
the Notch pathway) regulate the timing of final maturation in
different myelinated tracts (Blaschuk and ffrench-Constant,
1998). Unfortunately, further support for this model has not
been particularly forthcoming over the last years and several
crucial questions remain open: is the observed function of
Notch signaling in the control of rat OPC differentiation re-
stricted to the optic nerve or is it a general phenomenon
throughout the rodent CNS? Is the observed effect specifi-
cally Notch1 dependent or may other members of the Notch
family be involved (Notch 2–4; Lindsell et al., 1996; Irvin et
al., 2001)? Are the findings with isolated OPCs in vitro di-
rectly transferable to the in vivo situation, in particular given
the recent reappraisal that OL development is under stringent
axonal control and the proposed interactions of OPCs with
mature OLs via the Notch pathway in tissue (Wang et al.,
1998; Barres and Raff, 1999; Casaccia-Bonnefil, 2000)? The
“acid test” to answer these questions requires an analysis in a
physiologically accurate system in which specifically Notch1
has been reduced or eliminated. Transgenic mice provide
such a proper setting. 
 
Notch1
 
 knockout mice were not infor-
mative, however, due to early embryonic lethality (Swiatek et
al., 1994; Conlon et al., 1995). Thus, in this study we have
selectively inhibited Notch1 signaling using a conditional
 
Notch1
 
 knockout mouse strain (Radtke et al., 1999). Our
data demonstrate a crucial function of Notch1 in late steps of
OL differentiation in the spinal cord and suggest a similar
function in the brain.
 
Results
 
We have used a “floxed” allele of 
 
Notch1
 
, in which the exon
encoding the signal sequence (Fig. 1 A) is flanked by loxP
sites (Radtke et al., 1999) for conditional gene ablation. Re-
combination mediated by the Cre recombinase excises the
region between the lox sites, thereby inactivating the gene.
Cre was expressed under the control of regulatory elements
known to be active in the OL lineage, either those of the
 
Cnp 
 
gene (with the 
 
Cre
 
 coding region inserted into the en-
dogenous gene; unpublished data) or of the proteolipid (
 
Plp
 
)
gene (as a transgene driving 
 
Cre
 
; unpublished data) (Fig. 1
A). Newborn mice homozygous for the floxed 
 
Notch1
 
 allele
and carrying either the 
 
Cnp-Cre
 
 (
 
Cnp-Cre 
 

 
/
 

 
) or the 
 
Plp-
Cre
 
 (
 
Plp-Cre 
 

 
/
 

 
) allele were outwardly normal, nursed,
moved, breathed, and responded to mechanical stimulation,
but usually survived only a few hours after birth. Recombi-
nation outside the CNS was assessed in 
 
Cnp-Cre 
 

 
/
 

 
 mice
by reporter gene expression (for method, see next paragraph)
and was observed in various organs whose development is
known to be affected by Notch signaling, including kidney
(McLaughlin et al., 2000), liver (Nijjar et al., 2001), lung
(Ito et al., 2000), and pancreas (Apelqvist et al., 1999).
These findings could explain the early death of the 
 
Cnp-Cre
 

 
/
 

 
 animals. A small number of 
 
Cnp-Cre 
 

 
/
 

 
 individuals
survived longer, exhibited only modest defects (smaller in
size, poor sense of balance, and partially closed eyes), and
could be kept until adulthood. In contrast, 
 
Plp-Cre 
 

 
/
 

 
mice that survived after birth had to be killed because of se-
vere growth retardation and motor defects. Some 
 
Cnp-Cre
 

 
/
 

 
 and 
 
Plp-Cre 
 

 
/
 

 
 mice had strikingly enlarged lateral
ventricles at birth (unpublished data).
We focused our studies on the spinal cord because OL de-
velopment has been extensively studied in this structure. To
determine where and when Cre recombinase was produced
in the spinal cord in our Cre-transgenic mice, ROSA26 re-
porter (
 
R26R
 
) mice (Soriano, 1999) were crossed with mice
carrying 
 
Cnp-Cre
 
 (yielding 
 
Cnp-Cre R26R
 
) or 
 
Plp-Cre
 
 (yield-
ing 
 
Plp-Cre R26R
 
). This approach allowed lineage tracing
via detection of the 
 
LacZ
 
 product 
 

 
-galactosidase (
 

 
-gal;
Fig. 1 a). Sections were cut at the forelimb level of doubly
transgenic mice at embryonic day 13 (E13), and 
 

 
-gal was
detected by histological X-gal staining. In 
 
Cnp-Cre R26R
 
mice (Fig. 1 b, enlarged in d), X-gal–positive cells were ob-
served within the spinal cord in the ventral ventricular zone,
in a pattern consistent with recombination in OPCs as indi-
cated by PDGF receptor-
 

 
 (PDGFR-
 

 
) in situ hybridiza-
tion (Fig. 1 e). This restricted expression in OPCs was ex-
pected based on the reported endogenous 2
 

 
,3
 

 
-cyclic
nucleotide 3
 

 
-phosphodiesterase (CNP) expression in the rat
(Yu et al., 1994) and the analysis of transgenic mice under
the control of CNP regulatory elements (Gravel et al., 1998;
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Chandross et al., 1999). Additional recombination was ob-
served in the ventral horns of the neural tube, presumably in
developing motoneurons. Furthermore, X-gal–positive cells
were already found in the ventral ventricular zone as early as
E11.5 (unpublished data). By E17.5, the number of X-gal–
positive cells was increased substantially and the cells were
dispersed throughout the spinal cord (see Fig. 2 b), which is
consistent with the expected proliferation and migration of
OPCs (Miller et al., 1997). In contrast to the 
 
Cnp-Cre R26R
 
embryos, developing animals with a 
 
Plp-Cre
 
 
 
R26R
 
 genotype
showed a much broader pattern of 
 

 
-gal expression at E13
(Fig. 1 c), involving most of the cells in the spinal cord. This
is most likely an artifact of the transgene insertion because
expression of the endogenous 
 
Plp
 
 gene is more restricted (Yu
et al., 1994; Timsit et al., 1995). Therefore, further analysis
was performed mainly with the 
 
Cnp-Cre
 
 mice.
 
Precocious appearance of OLs in the spinal cord at E17.5
 
Next, we examined spinal cords at E17.5, shortly before OLs
start to accumulate in substantial numbers in the ventral fiber
tracts of the mouse thoracic spinal cord. Initial X-gal staining
in 
 
Cnp-Cre 
 

 
/
 

 
 R26R
 
 (Fig. 2 a) and 
 
Cnp-Cre 
 

 
/
 
wt R26R
 
(Fig. 2 b) embryos showed no major differences in the pat-
tern of recombined cells in the homozygous (
 

 
/
 

 
) compared
with heterozygous (
 

 
/
 
wt
 
) mice. We examined the cellular
composition of the neural tube in 
 
Cnp-Cre 
 

 
/
 

 
 versus con-
trol (
 
lox/lox
 
) mice using immunostaining and in situ hybrid-
ization for markers characteristic of neurons, astrocytes,
OPCs, and immature OLs. We used antibodies against neu-
ronal nuclear antigen (NeuN; Fig. 2, c and d), neurofilament
(unpublished data), and 
 

 
-tubulin III (unpublished data) for
neurons, glial fibrillary acidic protein (GFAP) for astrocytes
(Fig. 2, e and f), and detected PDGFR-
 

 
 by in situ hybrid-
ization for OPCs (Fig. 2, i and j). None of these markers
showed significant differences between mutant and control
mice. The number of neurons and astrocytes was indirectly
quantitated by determining the average overall intensity of
NeuN and GFAP immunostaining of 10 representative sec-
tions from three embryos of each genotype. Staining and im-
age processing were performed identically for sections of mu-
tant and control animals. No significant differences were
obtained, when intensity was calculated either per whole spi-
nal cord cross section (Fig. 2, g and h) or per unit area (un-
published data). The size of the white matter area (i.e., that
part of the spinal cord outside the area stained by NeuN) also
did not differ significantly (38 
 

 
 7.4 relative units for 
 
Cnp-
Cre 
 

 
/
 

 
 vs. 42 
 

 
 6.0 for control, P 
 
 
 
0.27, 
 
t
 
 test). However,
for immature OLs, the situation was quite different. The
number of cells expressing high levels of PLP/DM20 mRNA
(Fig. 2, k and l) was strongly increased in the spinal cord of
mutants compared with control animals, both in the gray
matter and in the future white matter (PLP/DM-20 has been
described to be expressed at earlier times in the ventral ven-
tricular zone, but expression outside this region is characteris-
tic of differentiated OLs; Richardson et al., 2000). An in-
 
Figure 1.
 
Experimental strategy and Cre-mediated recombination 
in OPCs at E13.
 
 (a) Schematic representation of the murine Notch1 
protein and LoxP/Cre-mediated deletion strategy. The Notch protein 
contains 2,531 amino acid residues that encompass a signal peptide, 
36 EGF repeats (EGF), 3 Lin/Notch domains (LN), a transmembrane 
domain (T), cytoplasmic ankyrin repeats, a polyglutamine stretch 
(Opa), and a PEST sequence. In the floxed 
 
Notch1
 
 allele (Radtke et 
al., 1999), the first coding exon is flanked by 
 
LoxP
 
 sequences (gray 
triangles). After Cre-mediated recombination, a null allele is gener-
ated. Arrows indicate EcoRI fragments that differ in size between the 
floxed locus compared with the locus after deletion of the 3.5-kb 
segment flanked by loxP sites. The Cre recombinase gene was 
inserted into the 
 
Cnp
 
 locus (
 
Cnp-Cre
 
) or is driven from Plp/DM20 
regulatory elements (Spassky et al., 1998) (
 
Plp-Cre
 
). The ROSA26 
reporter mouse (Soriano, 1999) (
 
R26R
 
) was used to follow recombi-
nation events: Cre-mediated recombination deletes the neomycin 
phosphotransferase gene (PGK-neo) plus four polyadenylation sites 
(4xpA), activating the production of 
 

 
-gal encoded by 
 
LacZ
 
. RI indi-
cates EcoRI restriction sites. (b–d) Cre-induced 
 

 
-gal expression pat-
terns. 
 
Cnp-Cre
 
 or 
 
Plp-cre
 
 mice were crossed with 
 
R26R
 
 reporter 
mice. Cells in which Cre had been expressed were detected by 
X-gal staining for 
 
-galactosidase activity in sections of E13 embryos. 
The Cnp-Cre line shows expression in the ventral ventricular zone 
(b, arrow) and motoneurons (b, asterisk); these regions are 
enlarged in panel d. The area indicated by an arrow (b and d) is 
the site of origin of the OPCs consistent with the expected endoge-
nous CNP expression pattern and confirmed by PDGFR- in situ 
hybridization (e). (b) Arrowheads indicate the nerve roots and dorsal 
root ganglia that are part of the PNS. Expression in the Plp-Cre line 
used is much broader, affecting most cells of the spinal cord (c). 
V, ventricle. Bars: 10 	m.
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creased number of differentiating OLs was also observed by
immunostaining for myelin-associated glycoprotein (MAG;
Fig. 2, m and n). We found 10-fold more perinuclear
MAG-positive cells per section compared with controls (Fig.
2 p). Interestingly, this increased number of immature
OLs was not the result of an increased number of OPCs
(PDGFR- mRNA–positive cells; Fig. 2 o). Furthermore, no
significant increase in proliferating cells was observed using
phosphorylated histone H3 as a marker for cells in the S
phase of the cell cycle (11.1  5.2 positive cells per section in
mutant animals vs. 10.1  3.9 in control animals).
Ectopic appearance of immature OLs 
in the gray matter at birth
Dramatic changes in the number and spatial distribution
of OLs were also evident in spinal cords of newborn (P0)
Cnp-Cre / compared with control (lox/lox) mice (Fig. 3,
compare c and e with d and f). Many immature OLs were
abnormally located in the gray matter. This altered distri-
bution was seen along the entire length of the spinal cord
in mutant mice (unpublished data). We quantified the
MAG-positive cells showing perinuclear staining (imma-
ture OLs; Fig. 3 i), using their perinuclear staining to dis-
tinguish them from myelinating mature OLs (Trapp et al.,
1997). After excluding the mature OLs at the ventral mar-
gin of both mutant and control spinal cords (Fig. 3, e and
f; see also MBP staining for mature OLs in Fig. 3, g and h
for comparison), there were approximately sixfold more
immature OLs present in mutants as compared with con-
trols (Fig. 3 l). Similar observations were made in Plp-Cre
/ mice (53  19 vs. 5  4 in mutant and control, re-
spectively). At E17.5, we found no difference between the
numbers of cells positive for PDGFR- mRNA in Cnp-Cre
/ and control mice (Fig. 3, a, b, and k).
Figure 2. Precocious differentiation of immature OLs in E17.5 spinal cord of Cnp-Cre / mice. (a and b) Sections were cut from triple 
transgenic animals carrying Cnp-Cre, R26R, and one (b) or two copies (a) of the floxed Notch1 allele. X-gal stainings indicate recombination 
with a similar pattern in homozygous mutant (a, /) or heterozygous mutant (b, /wt) spinal cords; motoneurons are indicated by arrows. 
Neurons, astrocytes, OPCs, and immature OLs were compared in Cnp-Cre / and control (lox/lox) spinal cords by immunohistochemistry 
(c–f, m, and n) or in situ hybridization (i–l). Neurons, astrocytes, and OPCs, assessed by the markers NeuN (c and d), GFAP (e and f), and 
PDGFR- (i and j), respectively, appear normal in conditional mutant animals (/) compared with control (lox/lox) littermates. Total image 
intensity was determined for 10 sections of each genotype. For NeuN (g), we integrated only in the region of the gray matter, and for GFAP (h) 
intensity was averaged over the whole spinal cord section. Intensities are in arbitrary units. The number of cells positive for PDGFR- mRNA 
was similar in mutant and control animals (o). By contrast, the number of immature OLs, assessed by counting cells positive for perinuclear 
MAG immunoreactivity (m and n) is significantly increased in mutant compared with control spinal cord (p, mean  SD; ***, P 
 0.001, t test). 
The precocious differentiation was confirmed by in situ hybridization for Plp/DM20 (k and l). Bar: (a–f and i–n) 10 	m.
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Increased apoptosis of prematurely differentiated OLs
Although we observed ectopic perinuclear MAG-positive
OLs in Cnp-Cre / mice, staining for MBP (a late marker
for myelinating OLs) was absent from the gray matter of
both thoracic (unpublished data) and cervical spinal cord
(Fig. 3, g and h), even though the latter is at a more ad-
vanced stage of differentiation than the thoracic segment.
However, some staining was observed in the future white
matter of both mutant and control animals (Fig. 3, g and h).
These observations raised the possibility that the ectopic im-
mature OLs might be cleared by programmed cell death. To
test this hypothesis, we double stained sections from Cnp-
Cre / spinal cords at P0 for TUNEL (Gavrieli et al.,
1992) and MAG (Fig. 3 j). Significantly more TUNEL-pos-
itive dying cells were found in mutant spinal cords: 14.9 
3.9 per section in mutants versus 7.8  2.3 per section in
controls (P 
 0.001, n  17, t test). Further, a higher per-
centage of MAG-positive cells were TUNEL-positive in mu-
tant mice (Fig. 3 m). Note that most, but not all, of the dy-
ing MAG-positive immature OLs were localized in the gray
matter. Together, these results suggest that the ectopic and
precociously appearing immature OLs are eliminated before
they fully differentiate into MBP-positive mature OLs.
Efficiency of Notch1 ablation
Because our multiple efforts to directly show elimination of
the Notch1 protein failed due to a lack of reliable reagents,
we demonstrated that Cre recombinase had been active in
the differentiating OLs. We prepared short-term cultures of
cells isolated from the spinal cord of single Cnp-Cre R26R
mice homozygous for the floxed Notch1 allele (/). Het-
erozygous littermates (/wt) were used as controls. The cells
were first stained with X-gal (Fig. 4, a and b) and then for
O4 (Fig. 4, c and d), a marker for both immature and ma-
ture OLs (Hardy and Reynolds, 1991). 89 out of 100 and
71 out of 100 O4-positive cells derived from homozygous
and heterozygous animals, respectively, were also positive for
-gal, demonstrating expression of Cre recombinase and ef-
ficient recombination of the R26R allele within the O4-pos-
itive cell population. To directly demonstrate Notch1 recom-
bination, DNA was isolated from spinal cords of newborn
mice and analyzed by Southern blotting (Fig. 4 e). Quantifi-
cation by PhosphorImager analysis revealed 20–25% re-
combination in Cnp-Cre / whole spinal cord, after nor-
malization to DNA isolated from control lox/0 mice.
Early stages of OPC development are normal 
in Notch1 mutant embryos
Because expression of Cre recombinase starts as early as
E11.5 in Cnp-Cre R26R mice (unpublished data), we exam-
ined the early development of OPCs in Cnp-Cre / mice.
PDGFR- mRNA–positive OPCs were found at E12.5 in
the neural tube in homozygous (/) as well as in heterozy-
gous (/wt) mice (unpublished data). At E14.5, the PDGFR-
mRNA-positive OPCs were dispersed throughout the cross
section (Fig. 5, a and b), and their number was similar in
mutants and controls (Fig. 5 g). MAG-positive cells were
not detected at this time point (Fig. 5, c and d). Thus, early
Figure 3. OPCs and immature OLs in P0 Cnp-Cre / spinal cord. Sections of thoracic spinal cord of Cnp-Cre / or control (lox/lox) mice 
were labeled with PDGFR- cRNA or PLP cRNA (a–d), with anti-MAG (e, f, and i) or anti-MBP (g and h) antibodies, or with MAG antibodies 
combined with TUNEL staining (j). The number and location of PDGFR-–positive OPCs was similar in mutant and control animals (a, b, and 
k). Also, the number and location of mature MBP-positive OLs in the developing white matter of the cervical spinal cord was not altered 
(g and h). In contrast, in the gray matter, there was a significant increase in ectopic immature OLs with extensive perinuclear MAG staining 
(i, quantified in panel l, mean  SD; ***, P 
 0.001). A subpopulation of these cells were TUNEL-positive (j, arrow). The percentage of apoptotic 
cells among perinuclear MAG-positive cells was significantly higher in mutant than in control spinal cord (m, 1,077 cells counted in mutant 
mice and 303 cells in control mice; [2 distribution] 2 86.29; **, P 
 0.005). Bars: (a–h) 100 	m; (i and j) 10 	m.
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development of the OL lineage appeared normal in Cnp-Cre
/ mice. The distribution of motoneurons showed no ma-
jor alterations in Cnp-Cre / mice at E12.5 (unpublished
data), E14.5 (Fig. 5, e and f, arrows), and E17.5 (Fig. 2, a
and b, arrows), as judged by immunostaining for the mark-
ers Isl1 and Isl2 (Tsuchida et al., 1994; Pfaff et al., 1996)
and X-gal staining in Cnp-Cre / R26R mice.
Precocious differentiation of OLs in the forebrain
We asked next whether precocious OL differentiation is
confined exclusively to the spinal cord. Thus, we examined
the forebrain, where OL differentiation starts slightly later
compared with the spinal cord. As in the spinal cord, abla-
tion of Notch1 in Cnp-Cre / mice led to a strong increase
in the number of perinuclear MAG-positive immature OLs
compared with controls, with a large fraction (50%)
found in the gray matter (Fig. 6, a–c). However, we did not
observe precocious differentiation using antibodies against
MAG in the optic nerve of P0 mutant animals (unpublished
data), likely because OL differentiation starts later in the op-
tic nerve.
Discussion
In the present paper, we used defined conditional gene abla-
tion to address the question of how the OL lineage is af-
fected when Notch1 function is specifically eliminated in
vivo. We provide direct evidence that Notch1 is critically
important for correct temporal and spatial differentiation of
OLs from the precursor to the immature stage in the mouse
spinal cord by demonstrating that ablation of Notch1 in
OPCs leads to ectopic production of prematurely differenti-
ated immature OLs. Most of the prematurely differentiated
OLs were found in the gray matter at P0 where immature
OLs are usually very scarce in control animals. Apoptosis
was strongly increased among the precociously differentiated
cells. However, the number of OPCs was not altered at the
ages examined, and early OL development appeared normal.
Precocious differentiation was also observed in the anterior
Figure 4. Recombination in cultured OL and efficiency of ablation 
of Notch1 in P0 Cnp-Cre / spinal cord. Acutely dissociated cells 
isolated from individual P0 Cnp-Cre R26R mice homozygous for the 
floxed Notch1 allele (a and c, /) or from Cnp-Cre R26R heterozy-
gous littermates (b and d, /wt) were stained for X-gal (a and b) and 
O4 (c and d). Arrows mark double-labeled cells. (e) Southern blot 
analysis of DNA isolated from P0 spinal cord using a probe derived 
from the 5 upstream region of the Notch1 locus revealed a 5.8-kb 
fragment from the wild-type allele after digestion with EcoRI. After 
recombination, a 2.3-kb fragment can be detected. Genotypes of 
the animals used are indicated above the lanes.
Figure 5. E14.5 spinal cord appears normal in Cnp-Cre / mice. 
Transverse sections of E14.5 Cnp-Cre / and control (lox/lox) 
spinal cords following in situ hybridization (a and b) or immunohisto-
chemistry (c–f). OPCs, OLs, and motoneurons were analyzed by the 
expression of PDGFR- mRNA (a and b), MAG (c and d), and Isl1/2, 
respectively. Comparable numbers of OPCs (g) and no MAG-
positive cells were observed. Motoneurons (e and f, arrows) appear 
normal; some interneurons and dorsal root ganglia are also marked 
by Isl1/2. Bar: 10 	m.
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forebrain, suggesting that Notch1 signaling may play an im-
portant role in OL development throughout the CNS.
An important issue is whether the observed effects of
Notch1 deletion on OPC differentiation depend directly on
deletion within the OPCs themselves or are an indirect con-
sequence of deletion in some other cell type. We used Cre-
mediated recombination driven by Cre recombinase inserted
into the Cnp locus. In agreement with published reports on
CNP regulation and according to our own data, in the devel-
oping spinal cord Cre recombinase was expressed exclusively
by early oligodendrocyte progenitors and motoneurons.
Given the pattern of X-gal and immunostaining at E17.5,
Cre is likely not to be expressed in astrocytes (Fig. 2, compare
b with f ). Development of neurons appears normal in the spi-
nal cords of mutant mice (Fig. 2, c, d, and g). However, we
cannot exclude subtle effects such as altered trophic support
or abnormal electrical signaling from the periphery. Electrical
activity of neurons has been shown to influence proliferation
of OPCs (Barres and Raff, 1993) and the process of myelina-
tion (Demerens et al., 1996), but we are not aware of evi-
dence that such electrical activity influences differentiation of
OPCs into immature OLs (for review see Barres and Raff,
1999). OLs develop normally in explant cultures from spinal
cord of Isl1/ mice (Sun et al., 1998), even though no mo-
toneurons or V1 interneurons are produced (Pfaff et al.,
1996). OLs also develop in hindbrain of Olig2/ mutants
(Lu et al., 2002), which lack somatic motoneurons. The
most likely interpretation of our results is therefore that they
reflect a direct effect of Notch1 deletion in OPCs.
Although -gal expression was seen as early as E11.5, the
first immature OLs were not found until E17.5. Several pos-
sibilities may be envisaged to explain this delay. Persistence
of Notch1 protein might render the cells effectively Notch1-
positive for some time after recombination has occurred.
This appears unlikely because, although we were not able to
directly assess the lifetime of the Notch1 protein, the pres-
ence of a PEST sequence near the COOH terminus suggests
that Notch1 turns over rapidly (Rechsteiner and Rogers,
1996). Alternatively, ablation of Notch1 might have an im-
mediate effect, but progress through the developmental pro-
gram might require several days (Durand and Raff, 2000).
This would be consistent with the clonal analyses of purified
precursor cells isolated from P7–8 (Barres et al., 1994) and
E18 rat optic nerve (Gao et al., 1998) suggesting that a cell
intrinsic program plays an important role in determining
when OPCs stop dividing and differentiate. Finally, Notch1
may inhibit the transition from OPCs to immature OLs
only relatively late in development, shortly before E17.5 in
the mouse spinal cord.
Why do many of the prematurely differentiated OLs in
Notch1 mutants die? Immunostaining with late differentia-
tion markers and assessment of apoptosis suggest that preco-
ciously differentiated OLs cannot terminally differentiate
and are unable to survive in the long term if they arise at the
wrong place and time, most likely due to missing appropri-
ate survival cues. Similar conclusions were reached by Calver
et al. (1998). Overexpression of PDGF led to the appear-
ance of an excess of immature OLs at ectopic sites in the
gray matter of transgenic spinal cords, due to an excess pro-
duction of OPCs, but the OLs survived in large numbers
only in white matter. In our study, the number of precursors
was normal, and it was precocious and uncontrolled differ-
entiation that led to a high number of immature OLs in the
gray matter. However, in both cases, these cells were elimi-
nated by apoptosis, and mature OLs accumulated only in
the white matter. It has been suggested that OPCs differen-
tiate preferentially in fiber tracts (Hardy and Friedrich,
1996). However, our results and those of Calver et al.
(1998) indicate that progenitor cells can differentiate both
in gray and white matter, but survive in large numbers only
in white matter.
The increase in immature OLs was not accompanied by a
decrease in the number of OPCs. It has been proposed that
expansion of OPCs is regulated by a density-dependent
mechanism (Zhang and Miller, 1996), which could have
served to prevent depletion of the OPC pool in our experi-
ments. We did not observe a significant increase in the num-
ber of proliferating cells. However, if the OLs live consider-
ably longer than the cell cycle time of the OPCs (which
ranges from 30 h at E13 to 100 h at E17; van Heynin-
gen et al., 2001), the expected increase in proliferation rate
might have escaped detection. We also considered the possi-
bility that Notch ablation might have produced MAG-posi-
tive OLs that were also still positive for early markers. We
tested this by coimmunostaining for MAG and the early
marker NG2, but found that the MAG-positive cells in the
gray matter were NG2 negative (unpublished data).
Our analysis demonstrates that Notch1 is required for the
regulation of the differentiation of OPCs to OLs, and thus
contributes to the timing of oligodendrocyte differentiation
in vivo. It has been suggested that this timing might be con-
trolled by an intrinsic mechanism that allows a single OPC
to undergo controlled cell cycle arrest and to differentiate in
vitro without neurons (Temple and Raff, 1986). Our data
and the observations by Wang et al. (1998) show that addi-
tional regulatory mechanisms that are mediated by direct
cell–cell interactions via the Notch1 receptor and its ligands
throughout the CNS are functional in this process. This
Figure 6. Precocious development of immature OLs in the cerebrum 
of P0 Cnp-Cre / mice. Transverse sections of P0 cerebrum were 
immunostained for MAG. (b) At P0, there were many immature 
(perinuclear MAG-positive) OLs present in the mutant brain (/), 
both in white matter (WM) and in gray matter (GM, here cortex, 
Co), whereas these were rare in the control (lox/lox) brain (c). These 
results are quantitated in panel a, which shows the mean number 
of cells (SD) with perinuclear MAG staining. Bar: 20 	m.
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most probably involves interactions between the axon and
OPCs but there might also be a contribution by interactions
between mature OLs and OPCs (Wang et al., 1998). The
intracellular mechanisms that underlie precocious OL differ-
entiation in the Notch conditional knockout animals remain
unknown at this stage. The finding that maturation of OLs
is strongly inhibited in the absence of the transcription fac-
tor Nkx2.2 (Qi et al., 2001) suggests the possibility that this
transcription factor or one of its regulatory targets is antago-
nized by the Notch signaling pathway.
Very recently, examination of mutants heterozygous for a
Notch1-null allele has provided evidence for an effect of
Notch1 on myelination (Givogri et al., 2002). Several
changes in the pattern of myelination were observed, includ-
ing premature myelination in the cortex, increased myelina-
tion of small caliber axons in the optic nerve, and ectopic
myelination in the molecular layer of the cerebellum. Some
of these changes may reflect premature differentiation of
OPCs, such as we describe here but in the heterozygous-null
setting, there also seem to be effects on survival of OLs and
on the choice of axons to be myelinated.
Cell–cell interactions mediated by Notch signaling are
likely to play a pivotal role in development as part of a local
regulatory circuit that forms the basis for the asynchronous
myelination of the CNS and its different fiber tracts. The fi-
nal trigger for OL differentiation is likely to be a down-regu-
lation of the axonal component of the Notch1–ligand inter-
action, possibly linked to electrical activity (Rogister et al.,
1999). Likewise, OPCs in the adult nervous system might be
held in the undifferentiated state via this regulatory system. If
correct, inhibition of Notch1 might be an effective way of ac-
tivating these quiescent cells for repair in demyelinating dis-
eases like multiple sclerosis. This is particularly warranted by
the fact that lesions in multiple sclerosis are not starved of
OPCs as previously thought, but rather that other factors,
possibly including activated Notch signaling, are responsible
for the failure of remyelination (Solanky et al., 2001).
Materials and methods
Mice
Mice carrying LoxP-flanked Notch1 alleles have been described previously
(Radtke et al., 1999). Recombination between the LoxP sites reduces ex-
pression of Notch1 protein to undetectable levels, and no shorter frag-
ments are seen (Wolfer et al., 2001). Mice carrying the Cre recombinase
under the transcriptional control of the Plp (line PLCD) and Cnp regulatory
elements will be described elsewhere. The ROSA26 mouse reporter line
was provided by Dr. P. Soriano (Soriano, 1999). Embryos were generated
by timed mating, counting the morning after pairing as E0.5. Procedures
for animal experiments were approved by the Veterinary Office of the Can-
ton of Zurich (permit 113/99).
For most experiments, we compared Cnp-Cre / or Plp-Cre / ani-
mals with lox/lox littermates as a control. Findings were reproduced from
at least three animals of each genotype and from at least two different lit-
ters. Spinal cord sections were cut at the forelimb level in embryos and at
the thoracic level in newborns, unless otherwise indicated. The lateral
ventricles were used as landmarks for the brain sections.
X-gal histochemistry, in situ hybridization, 
immunofluorescence, and TUNEL staining
Timed pregnant mothers were killed, and embryos were isolated, fixed for
1–2 h in 4% paraformaldehyde, incubated for a few hours to overnight in
30% sucrose, embedded in OCT (TissueTech), and immediately frozen on
dry ice. Newborns were anesthetized by intraperitoneal injection of a pento-
barbital solution, and then perfused with a 0.9% saline solution followed by
4% ice-cold paraformaldehyde. Brains and spinal cords were isolated, fixed
for 24–72 h in the same fixative at 4C, incubated in 30% sucrose overnight,
and embedded in OCT. 20-	m (embryos) or 5-	m (newborn)–frozen sec-
tions were thaw-mounted onto Superfrost slides (Mettler) and air dried.
For the X-gal staining, the sections were incubated overnight in a PBS
solution containing 5 mM potassium ferrocyanide, 5 mM potassium ferri-
cyanide, 2 mM magnesium chloride, and 2 mM X-gal (Calbiochem). In situ
hybridizations were performed with digoxigenin-labeled RNA probes
overnight at 72C in buffer containing 50% formamide and detected using
an anti–DIG-AP antibody according to the manufacturer’s instructions
(Roche Diagnostics). The PDGFR- and PLP/DM20 plasmids were gifts
from Drs. W.D. Richardson and B. Zalc, respectively. Immunohistochem-
istry was performed overnight at 4C with antibodies against NeuN (1:100;
Chemicon Inc.), GFAP (1:500; Accurate), -tubulin III (1:300; Sigma-
Aldrich), neurofilament 160 (1:20; Sigma-Aldrich) and phosphorylated his-
tone H3 (1:100; Upstate Biotechnology). Antibodies against MBP (1:500),
PLP/DM20 (1:500), Isl1/2 (1:500), and MAG (1:500) were provided by Drs.
N. Baumann, I.R. Griffiths, T.M. Jessell, and J.L. Salzer, respectively. Sec-
ondary antibody incubations (1:300; Jackson Immunochemicals) were per-
formed for 1 h at room temperature.
Apoptotic cell death was analyzed by TUNEL staining using biotin-
labeled UTP and an FITC-conjugated streptavidin complex according to
the manufacturer’s instructions (Roche Diagnostics).
Images were collected using an Axiophot microscope (Carl Zeiss Mi-
croImaging, Inc.) in conjunction with a ProgRes 3008 (Jenoptik) or
Hamamatsu CCD camera. Image processing was performed with Adobe
Photoshop® 5.0 software. Staining intensity was measured with NIH Image
1.62 software. The number of cells expressing PDGFR- mRNA or show-
ing perinuclear MAG staining was determined by counting all cells in at
least 10 sections.
Primary cell dissociation
Spinal cords were individually isolated from newborn animals by incuba-
tion for 20 min at 37C in 200 	l DME medium (Life Technologies) con-
taining 2 mg/ml collagenase type IV (Worthington Biochemical Corp.), 1.2
mg/ml hyaluronidase type IV-S (Sigma-Aldrich) and 0.3 mg/ml trypsin in-
hibitor (Sigma-Aldrich). After trituration, dissociated cells were plated onto
poly-D-lysine (Sigma-Aldrich)–coated dishes (35 mm; Corning) in Eagle’s
medium with 10% FCS (Sera-Tech) and maintained at 37C in 5% CO2
overnight. These cells were used for X-gal and O4 staining (Fig. 4, a–d).
The carcasses were genotyped by PCR.
Southern blot and quantification
Spinal cord was isolated from newborn animals and cells were mechani-
cally dissociated as previously described (Milner and Ffrench-Constant,
1994). Southern blotting (5 	g EcoRI-digested genomic DNA) to a Hy-
bond™-N membrane (Amersham Biosciences) was performed essentially
as described by Radtke et al. (1999), using as probe a 750-bp BamHI-
EcoRI fragment derived from the 5 upstream region of the Notch1 locus.
The probe was hybridized at 42C, and the signals quantified using a Phos-
phorImager (Storm 820; Molecular Dynamics).
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